BOUNCE BIOMEDICAL LIMITED

Active Abingdon

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
B

BOUNCE BIOMEDICAL LIMITED

Research and experimental development on biotechnology

Founded 30 May 2008 Active Abingdon, United Kingdom 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

ORTHOX LIMITED 30 May 2008 — 22 Aug 2025
Accounts Submitted 16 Jul 2025 Next due 30 Nov 2026 5 months remaining
Confirmation Submitted 4 Jun 2025 Next due 13 Jun 2026 6 days remaining
Net assets £-2M £531K 2024 year on year
Total assets £2M £515K 2024 year on year
Total Liabilities £4M £15K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

66 Innovation Drive Milton Park Abingdon OX14 4RQ United Kingdom

Telephone

0800 000 0000

Website

www.example.com

Full company profile for BOUNCE BIOMEDICAL LIMITED (06606448), an active life sciences and medical technology company based in Abingdon, United Kingdom. Incorporated 30 May 2008. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Mar → 28 Feb 2025
Type small
Next accounts 28 Feb 2026
Due by 30 Nov 2026 5 months remaining

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£349.66k

Decreased by £1.57M (-82%)

Net Assets

-£1.91M

Decreased by £530.62k (-38%)

Total Liabilities

£4.30M

Increased by £15.41k (+0%)

Turnover

N/A

Employees

3

Decreased by 7 (-70%)

Debt Ratio

180%

Increased by 32 (+22%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
28 Feb Year End
2024
29 Feb Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 6
Grants 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 9Jun 2015Series A
Investor 5Aug 2018Seed
Investor 7Feb 2022Series A

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 4,440 Shares £20k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Mar 20104,440£20k£4.44

Officers

Officers

1 active 2 resigned
Status
Nicholas James Vavasour SkaerDirectorBritishEngland5230 May 2008Active

Shareholders

Shareholders (1)

Orthox Holdings Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

BOUNCE BIOMEDICAL LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
66 Innovation Drive, Milton Park, Milton, Abingdon (OX14 4RQ) VALE OF WHITE HORSE
Leasehold-5 Oct 2015
66 Innovation Drive, Milton Park, Milton, Abingdon (OX14 4RQ)
Leasehold
Added 5 Oct 2015
District VALE OF WHITE HORSE

Documents

Company Filings

DateCategoryDescriptionDocument
14 Jan 2026OfficersChange to director Dr Friedrich Wilhelm Ludwig Paul Vollrath on 14 Jan 2026
22 Aug 2025Change Of NameCertificate Change Of Name Company
16 Jul 2025AccountsAnnual accounts made up to 28 Feb 2025
17 Jun 2025OfficersAppointment of Prof Oliver Christoph Kessler as director
4 Jun 2025Confirmation StatementConfirmation statement made on 30 May 2025 with no updates
14 Jan 2026 Officers

Change to director Dr Friedrich Wilhelm Ludwig Paul Vollrath on 14 Jan 2026

22 Aug 2025 Change Of Name

Certificate Change Of Name Company

16 Jul 2025 Accounts

Annual accounts made up to 28 Feb 2025

17 Jun 2025 Officers

Appointment of Prof Oliver Christoph Kessler as director

4 Jun 2025 Confirmation Statement

Confirmation statement made on 30 May 2025 with no updates

Recent Activity

Latest Activity

Change to director Dr Friedrich Wilhelm Ludwig Paul Vollrath on 14 Jan 2026

4 months ago on 14 Jan 2026

Certificate Change Of Name Company

9 months ago on 22 Aug 2025

Annual accounts made up to 28 Feb 2025

10 months ago on 16 Jul 2025

Appointment of Prof Oliver Christoph Kessler as director

11 months ago on 17 Jun 2025

Confirmation statement made on 30 May 2025 with no updates

1 years ago on 4 Jun 2025